The estimated Net Worth of Jesse Chew is at least $1.63 million dollars as of 30 November 2023. Mr Chew owns over 29,770 units of Accuray Inc stock worth over $752,382 and over the last 6 years he sold ARAY stock worth over $258,947. In addition, he makes $621,118 as Sr. VP et Gen. Counsel & Corp. Sec. at Accuray Inc.
Sign up
Mr Chew ARAY stock SEC Form 4 insiders trading
Mr has made over 13 trades of the Accuray Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 29,770 units of ARAY stock worth $73,532 on 30 November 2023.
The largest trade he's ever made was selling 29,770 units of Accuray Inc stock on 30 November 2023 worth over $73,532. On average, Mr trades about 5,235 units every 109 days since 2018. As of 30 November 2023 he still owns at least 381,920 units of Accuray Inc stock.
You can see the complete history of Mr Chew stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Jesse Chew biography
Jesse Chew is the Sr. VP, Gen. Counsel & Corp. Sec. at Accuray Inc.
What is the salary of Mr Chew?
As the Sr. VP et Gen. Counsel & Corp. Sec. of Accuray Inc, the total compensation of Mr Chew at Accuray Inc is $621,118. There are 7 executives at Accuray Inc getting paid more, with Ali Pervaiz having the highest compensation of $5,183,662.
How old is Mr Chew?
Mr Chew is 40, he's been the Sr. VP et Gen. Counsel & Corp. Sec. of Accuray Inc since . There are 14 older and 1 younger executives at Accuray Inc. The oldest executive at Accuray Inc is Elizabeth Davila, 75, who is the Independent Director.
What's Mr Chew's mailing address?
Jesse's mailing address filed with the SEC is 1310, Chesapeake Terrace, Sunnyvale, Santa Clara County, California, 94089, United States.
Insiders trading at Accuray Inc
Over the last 18 years, insiders at Accuray Inc have traded over $37,863,458 worth of Accuray Inc stock and bought 806,995 units worth $5,047,672 . The most active insiders traders include International Investment Ho..., Robert S Weiss et Euan Thomson. On average, Accuray Inc executives and independent directors trade stock every 24 days with the average trade being worth of $62,792. The most recent stock trade was executed by Ali Pervaiz on 4 September 2024, trading 8,404 units of ARAY stock currently worth $17,312.
What does Accuray Inc do?
accuray incorporated (nasdaq: aray) is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. the company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. for more information, please visit www.accuray.com. for career opportunities, please visit http://www.accuray.com/careers.
What does Accuray Inc's logo look like?
Complete history of Mr Chew stock trades at Accuray Inc
Accuray Inc executives and stock owners
Accuray Inc executives and other stock owners filed with the SEC include:
-
Ali Pervaiz,
Sr. VP & CFO -
Joshua Levine,
President, Chief Executive Officer, Director -
Joshua H. Levine,
CEO & Director -
Shigeyuki Hamamatsu,
Chief Financial Officer, Senior Vice President -
Patrick Spine,
Senior Vice President, Chief Administrative Officer -
Suzanne Winter M.B.A.,
Pres -
Patrick R. Spine,
Sr. VP & Chief Admin. Officer -
Jesse Chew,
Sr. VP, Gen. Counsel & Corp. Sec. -
Joseph Whitters,
Independent Director -
Louis Lavigne,
Independent Chairperson of the Board -
Elizabeth Davila,
Independent Director -
Richard Pettingill,
Independent Director -
Beverly Huss,
Independent Director -
Anne Le Grand,
Director -
Michael Polyviou,
IR Contact Officer -
Jesse Chew,
Senior Vice President, General Counsel, Secretary -
James Hindman,
Independent Director -
Suzanne Winter,
Senior Vice President, Chief Commercial Officer -
Franco N. Palomba,
VP, Chief Accounting Officer & Controller -
Scott Chapman,
Sr. VP of Global Service -
Beth Kaplan,
PR Director -
Ken Mobeck,
VP of Fin. & Investor Relations -
Dr. Jean-Philippe Pignol,
Sr. VP, Chief Medical & Technology Officer -
Michael Hoge,
Sr. VP of Global Operations -
Brandon Wegner Green CPA,
Interim Chief Financial Officer -
Lionel Hadjadjeba,
SVP & Chief Customer Experienc -
Kevin Waters,
SVP, Chief Financial Officer -
Dennis L Winger,
Director -
Robert S Weiss,
Director -
Jack Goldstein,
Director -
Emad T. Rizk,
Director -
Alaleh Nouri,
VP, Interim General Counsel -
Kelly Londy,
SVP, Chief Commercial Officer -
Eric Lindquist,
Sr. VP, CMO -
Eric Pauwels,
SVP Chief Marketing Officer -
Byron C Scott,
-
Mika Nishimura,
-
Franco N Palomba,
VP, Chief Accounting Officer -
Ali Pervaiz,
SVP Chief Financial Officer -
Sandeep Chalke,
SVP, Chief Commercial Officer -
Andrew J Kirkpatrick,
SVP & COO -
Li Yu,
Director -
John P Wareham,
Director -
International Investment Ho...,
10% owner -
Michael Hoge,
Senior VP Global Operations -
John Adler,
Director -
Robert Mc Namara,
SVP Chief Financial Officer -
Wade Hampton,
SVP CSO -
Ted T.C. Tu,
Director -
Christopher D Mitchell,
SVP, General Counsel -
Gregory Lichtwardt,
EVP, Chief Financial Officer -
Robert P Ragusa,
SVP Global Operations -
Darren J. Milliken,
SVP, Gen Counsel & Corp Sec. -
Theresa L Dadone,
SVP Human Resources -
Chris Raanes,
Sr. VP, COO -
Derek A Bertocci,
Senior Vice President & Chief -
Wayne Wu,
Director -
Peter Fine,
Director -
Brandon W Green,
VP, Interim CFO -
Robert Kill,
-
G Ina Corradetti,
VP, CAO and Controller